CRSP - Vertex announces Saudi Arabian approval of Casgevy for sickle cell TDT
2024-01-09 13:40:50 ET
More on CRISPR Therapeutics, Vertex Pharmaceuticals, etc.
- Vertex Pharmaceuticals Incorporated (VRTX) J.P. Morgan 42nd Annual Healthcare Conference
- Vertex Pharmaceuticals: A Full Pipeline
- CRISPR Therapeutics: Therapies Of The Future Are Almost Here, But Not Yet
- Vertex unit ViaCyte opts out of CRISPR diabetes program
- CRISPR, bluebird stocks slide as Agios rallies on thalassemia study
For further details see:
Vertex announces Saudi Arabian approval of Casgevy for sickle cell, TDT